Vifor Pharma AG
Vifor Pharma's GHG Emissions Data Preview
In 2020, Vifor Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
Vifor Pharma has also provided a category-level breakdown for 3 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Vifor Pharma's Operational Emissions
In 2020, the total operational greenhouse gas (GHG) emissions of Vifor Pharma amounted to 6,785 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2019, the total operational greenhouse gas (GHG) emissions of Vifor Pharma decreased by 23.13%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
Vifor Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Vifor Pharma's Scope 1 emissions?
In 2020, the total Scope 1 emissions of Vifor Pharma were 6,274 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Vifor Pharma reduced its Scope 1 emissions over time?
Since 2018, Vifor Pharma's Scope 1 emissions have decreased by 17.99%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2019), Vifor Pharma's Scope 1 emissions decreased by 22.33%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are Vifor Pharma's Scope 2 emissions?
In 2020, Vifor Pharma reported Scope 2 greenhouse gas (GHG) emissions of 511 tCOâ‚‚e without specifying the calculation method.
Has Vifor Pharma reduced its Scope 2 emissions over time?
Since 2018, Vifor Pharma's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 61.38%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2019), Vifor Pharma's Scope 2 emissions (Unspecified Calculation Method) fell by 31.78% in 2020, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.
What methodology does Vifor Pharma use for Scope 2 reporting?
In 2020, Vifor Pharma reported its Scope 2 emissions using an unspecified methodology.
Vifor Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Vifor Pharma's Value Chain Emissions
In 2020, Vifor Pharma reported 6,771 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2020 disclosure of Vifor Pharma includes a breakdown across 3 of the 15 Scope 3 categories defined by the GHG Protocol, up from 2 in 2019, reflecting improved emissions accounting practices and greater transparency across the company's value chain
Vifor Pharma's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Vifor Pharma's Scope 3 emissions?
In 2020, Vifor Pharma reported total Scope 3 emissions of 6,771 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.
Has Vifor Pharma reduced its Scope 3 emissions over time?
Since 2018, Vifor Pharma's Scope 3 emissions have decreased by 25.11%, reflecting a declining long-term trend in Scope 3 emissions over time.
Compared to the previous year (2019), Vifor Pharma's Scope 3 emissions decreased by 36.44%, highlighting the company's efforts to lower indirect emissions from its value chain.
What categories of Scope 3 emissions does Vifor Pharma disclose?
In 2020, Vifor Pharma reported emissions for 3 out of the 15 Scope 3 categories defined by the GHG Protocol.
The limited disclosure restricts visibility into specific emission sources across the company's value chain.
What are the main sources of Vifor Pharma's Scope 3 emissions?
In 2020, the largest contributors to Vifor Pharma's Scope 3 emissions were:
- Downstream Transportation and Distribution (Cat. 9): 5,100 tCOâ‚‚e (75.32%)
- Business Travel (Cat. 6): 992 tCOâ‚‚e (14.65%)
- Upstream Transportation and Distribution (Cat. 4): 679 tCOâ‚‚e (10.03%)
Vifor Pharma's Scope 3 Emissions by Categories
Insights into Vifor Pharma's Total Carbon Footprint
In 2020, Vifor Pharma reported a total carbon footprint of 13,556 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 30.41% decrease compared to 2019, indicating progress in reducing its overall greenhouse gas output.
The largest contributor to Vifor Pharma's total carbon footprint was Scope 3 emissions, accounting for 49.95% of the company's total carbon footprint, followed by Scope 1 emissions at 46.28%.